Federal News
Congress Introduces Bioindustrial Scale-Up Legislation
March 18, 2026
Congressman Jim Baird introduced the Bioindustrial Scale-Up for Supply Chains and Energy Resiliency Act of 2026 to establish bioindustrial scale-up facilities under the U.S. Department of Energy. This bipartisan legislation aims to accelerate emerging bioindustrial technologies, enhance U.S. biotechnology competitiveness, and strengthen supply chains and energy resiliency. The bill has garnered support from multiple representatives and emphasizes coordination with relevant federal facilities, including the Department of Defense, to promote economic growth through biotechnology innovation.
- Why this matters: The legislation signals forthcoming federal investment in bioindustrial infrastructure, creating potential procurement opportunities for contractors specializing in biotechnology, manufacturing scale-up, and related facility development.
- Procurement professionals should prepare for new DOE solicitations related to bioindustrial technology scale-up facilities and associated services.
- Companies in biotech manufacturing and supply chain solutions may find increased demand as the government seeks to strengthen domestic production capabilities.
- Coordination with defense-related bioindustrial efforts suggests cross-agency collaboration opportunities for contractors with dual-use technology expertise.
As a farmer and scientist, I know how important biotechnology is to strengthening our world-class agriculture industry. To ensure our country continues to lead the world in biotechnology, we must promote opportunities to develop new products and move them to market.
— Congressman Jim Baird
This legislation will help accelerate emerging bioindustrial technologies, including through coordination with relevant facilities such as the Department of Defense, to strengthen our supply chains and energy resiliency.
— Representative Stephanie Bice
The U.S. is by far the leader in biotech innovation, but we lack the infrastructure to keep up with the demand despite having all the necessary elements to biomanufacture American innovations.
— Senator Todd Young
Agencies
U.S. Department of Energy, National Security Commission on Emerging Biotechnology, U.S. House of Representatives